Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2014, Article ID 510916, 7 pages
http://dx.doi.org/10.1155/2014/510916
Research Article

Acute Effects of Exogenous Hormone Administration on Postprandial Acylation Stimulating Protein Levels in Ovariectomized Rats after a Fat Load

1Department of Biochemistry, College of Medicine, Sultan Qaboos University, Al-Khod, 123 Muscat, Oman
2Department of Microbiology and Immunology, College of Medicine, Sultan Qaboos University, Al-Khod, 123 Muscat, Oman
3Department of Animal and Veterinary Sciences, College of Agricultural and Marine Sciences, Sultan Qaboos University, Al-Khod, 123 Muscat, Oman

Received 30 June 2014; Accepted 14 November 2014; Published 2 December 2014

Academic Editor: Duo Li

Copyright © 2014 Bashair Al Riyami et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Cianflone, Z. Xia, and L. Y. Chen, “Critical review of acylation-stimulating protein physiology in humans and rodents,” Biochimica et Biophysica Acta: Biomembranes, vol. 1609, no. 2, pp. 127–143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Murray, A. D. Sniderman, P. J. Havel, and K. Cianflone, “Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice,” The Journal of Biological Chemistry, vol. 274, no. 51, pp. 36219–36225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Faraj, A. D. Sniderman, and K. Cianflone, “ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes,” Journal of Lipid Research, vol. 45, no. 4, pp. 657–666, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. V. van Harmelen, S. Reynisdottir, K. Cianflone et al., “Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin,” The Journal of Biological Chemistry, vol. 274, no. 26, pp. 18243–18251, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Maslowska, T. Scantlebury, R. Germinario, and K. Cianflone, “Acute in vitro production of ASP in differentiated adipocytes,” Journal of Lipid Research, vol. 38, no. 1, pp. 21–31, 1997. View at Google Scholar · View at Scopus
  6. S. Paglialunga, A. Fisette, Y. Yan et al., “Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice,” American Journal of Physiology: Endocrinology and Metabolism, vol. 294, no. 3, pp. E521–E529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Paglialunga, A. Fisette, M. Munkonda, Y. Gao, D. Richard, and K. Cianflone, “The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice,” BMC Physiology, vol. 10, no. 1, article 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Cianflone, R. Zakarian, C. Couillard, B. Delplanque, J.-P. Despres, and A. Sniderman, “Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance,” Journal of Lipid Research, vol. 45, no. 1, pp. 124–131, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Mohamed-Ali, J. H. Pinkney, and S. W. Coppack, “Adipose tissue as an endocrine and paracrine organ,” International Journal of Obesity, vol. 22, no. 12, pp. 1145–1158, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. P. S. Cooke and A. Naaz, “Role of estrogens in adipocyte development and function,” Experimental Biology and Medicine, vol. 229, no. 11, pp. 1127–1135, 2004. View at Google Scholar · View at Scopus
  11. M. J. Lobo, X. Remesar, and M. Alemany, “Effect of chronic intravenous injection of steroid hormones on body weight and composition of female rats,” Biochemistry and Molecular Biology International, vol. 29, no. 2, pp. 349–358, 1993. View at Google Scholar · View at Scopus
  12. R. Ahmadi and S. H. Oryan, “Effects of ovariectomy and estradiol valerate or progestetone on serum insulin level in rats,” International Journal of Medicine and Medical Sciences, vol. 1, no. 6, pp. 263–266, 2009. View at Google Scholar
  13. J. Saleh, M. Al-Khanbashi, M. Al-Maarof, M. Al-Lawati, S. G. Rizvi, and K. Cianflone, “Acylation-stimulating protein increases and correlates with increased progesterone levels during the luteal phase of the menstrual cycle,” European Journal of Endocrinology, vol. 160, no. 2, pp. 301–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Saleh, K. Cianflone, T. Chaudhary, H. Al-Riyami, A.-R. Al-Abri, and R. Bayoumi, “Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation,” Obesity, vol. 15, no. 3, pp. 646–652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Saleh, H. D. S. Al-Riyami, T. A. Chaudhary, and K. Cianflone, “Cord blood ASP is predicted by maternal lipids and correlates with fetal birth weight,” Obesity, vol. 16, no. 6, pp. 1193–1198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Wu, J. Zhang, Y. Wen, H. Wang, M. Zhang, and K. Cianflone, “Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome,” Fertility and Sterility, vol. 91, no. 1, pp. 213–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Oktenli, T. Ozgurtas, M. Dede et al., “Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome,” Gynecological Endocrinology, vol. 23, no. 12, pp. 710–715, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Saleh, N. Al-Wardy, H. Farhan, M. Al-Khanbashi, and K. Cianflone, “Acylation stimulating protein: a female lipogenic factor?” Obesity Reviews, vol. 12, no. 6, pp. 440–448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. C. Murphy, P. Pezuk, M. Menaker, and M. T. Sellix, “Effects of ovarian hormones on internal circadian organization in rats 2013,” in Proceedings of the 45th Annual Meeting of the Society for the Study of Reproduction, 2013.
  20. H. B. Waynforth and P. A. Flecnell, Experimental and Surgical Technique in the Rat, Academic Press, London, UK, 2nd edition, 1992.
  21. A. Liu, L. Gao, S. Kang et al., “Testosterone enhances estradiol's cardioprotection in ovariectomized rats,” Journal of Endocrinology, vol. 212, no. 1, pp. 61–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-L. Lu, J.-C. Hsieh, M.-L. Tsaur et al., “Estrogen rapidly modulates mustard oil-induced visceral hypersensitivity in conscious female rats: a role of CREB phosphorylation in spinal dorsal horn neurons,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 292, no. 1, pp. G438–G446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. R. R. Gangula, S. J. Wimalawansa, and C. Yallampalli, “Pregnancy and sex steroid hormones enhance circulating calcitonin gene-related peptide concentrations in rats,” Human Reproduction, vol. 15, no. 4, pp. 949–953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Arkaravichien and K. E. Kendle, “Critical progesterone requirement for maintenance of pregnancy in ovariectomized rats,” Journal of Reproduction and Fertility, vol. 90, no. 1, pp. 63–70, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. K.-H. Diehl, R. Hull, D. Morton et al., “A good practice guide to the administration of substances and removal of blood, including routes and volumes,” Journal of Applied Toxicology, vol. 21, no. 1, pp. 15–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Damsch, G. Eichenbaum, A. Tonelli et al., “Gavage-related reflux in rats: identification, pathogenesis, and toxicological implications (Review),” Toxicologic Pathology, vol. 39, no. 2, pp. 348–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Saleh, L. K. M. Summers, K. Cianflone, B. A. Fielding, A. D. Sniderman, and K. N. Frayn, “Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period,” The Journal of Lipid Research, vol. 39, no. 4, pp. 884–891, 1998. View at Google Scholar · View at Scopus
  28. S. Meijssen, H. van Dijk, C. Verseyden, D. W. Erkelens, and M. C. Cabezas, “Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 5, pp. 811–816, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Saleh, J. E. Blevins, P. J. Havel, J. A. Barrett, D. W. Gietzen, and K. Cianflone, “Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents,” International Journal of Obesity, vol. 25, no. 5, pp. 705–713, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Rezvani, A. Gupta, J. Smith et al., “Cross-sectional associations of acylation stimulating protein (ASP) and adipose tissue gene expression with estradiol and progesterone in pre- and postmenopausal women,” Clinical Endocrinology, vol. 81, no. 5, pp. 736–745, 2014. View at Publisher · View at Google Scholar
  31. Y. Wen, H. Wang, R. MacLaren, H. Lu, X.-F. Hu, and K. Cianflone, “Sex steroid hormones induce acylation stimulating protein resistance in 3T3-L1 adipocytes,” Journal of Cellular Biochemistry, vol. 105, no. 2, pp. 404–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Liu and L. Lv, “Effect of hormone replacement therapy on serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels in post-menopausal women,” Journal of Huazhong University of Science and Technology: Medical Sciences, vol. 28, no. 1, pp. 102–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Scantlebury, M. Maslowska, and K. Cianflone, “Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes,” The Journal of Biological Chemistry, vol. 273, no. 33, pp. 20903–20909, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Zhang, Y. Liu, L. Wang et al., “Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat,” Journal of Lipid Research, vol. 54, no. 2, pp. 345–357, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. K. Kalkhoff, “Metabolic effects of progesterone,” American Journal of Obstetrics and Gynecology, vol. 142, no. 6, pp. 735–738, 1982. View at Google Scholar · View at Scopus
  36. S. B. Pedersen, K. Kristensen, and B. Richelsen, “Anti-glucocorticoid effects of progesterone in vivo on rat adipose tissue metabolism,” Steroids, vol. 68, no. 6, pp. 543–550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Lacasa, E. Garcia, B. Agli, and Y. Giudicelli, “Control of rat preadipocyte adipose conversion by ovarian status: regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways,” Endocrinology, vol. 138, no. 7, pp. 2729–2734, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Björntorp, “Hormonal control of regional fat distribution,” Human Reproduction, vol. 12, no. 1, pp. 21–25, 1997. View at Google Scholar · View at Scopus
  39. A. Selvamani and F. Sohrabji, “The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1,” The Journal of Neuroscience, vol. 30, no. 20, pp. 6852–6861, 2010. View at Publisher · View at Google Scholar · View at Scopus